User:Pinpinn/sandbox

HORIBA Medical
Trade name	HORIBA Medical
Formerly	HORIBA ABX SAS
Founded	France (1983; 41 years ago)
Fate	Acquired by Horiba Group (in 1996)
Products	In vitro diagnostic instruments
Parent	Horiba

Horiba, Ltd.
Company type	Public KK
Traded as	TYO: 6856
Industry	Electronics/Measurement Instruments
Founded	Kyoto, Japan
Founder	Masao Horiba
Headquarters	2 Miyanohigashi, Kisshoin, Minami-ku Kyoto, 601-8510 Japan
Area served	Worldwide
Key people	Atsushi Horiba; (Chairman & Group CEO)
Products	The Company manufactures and sells automotive emission measurement systems, environmental measuring instruments, wide range of scientific analyzers, and medical diagnostic analyzers, and measuring equipment used in the semi-conductor industry. HORIBA also manufactures and markets peripheral measuring and analysis devices. Moreover, the Company equips such facilities as laboratories with measuring and analytical equipment for R&D, production, and other applications.;
Revenue	US$ 1,887 million (FY 2019); (¥ 200,241 million) (FY 2019)
Net income	US$ 145 million (FY 2019); (¥ 15,481 million) (FY 2019)
Number of employees	8,288 (As of December 31, 2019)
Subsidiaries	List
Website	Official website
	Footnotes / references;

Horiba, Ltd. (堀場製作所, Kabushiki-gaisha Horiba Seisaku-sho) is a Japanese manufacturer of precision instruments for measurement and analysis. They make instruments that measure and analyze automobile exhaust gas (80% share of the world market),^[4] and environmental, medical and scientific applications.

Horiba is one of the top 25 analytical and life sciences instrumentation companies in the world.^[5]

The group has been involved in measurement technology for more than 50 years.^{[citation needed]} It is diversified in 5 different sectors: automotive tests systems (36% activity), environmental (11%), medical (17%), semiconductor (19%) and scientific fields (17%). Today, the group, chaired by Atsushi Horiba, gathers 5,965 employees worldwide and generated 1 294 million of dollars in 2014.^{[dubious – discuss]}

The moto of HORIBA Ldt. is "Joy and Fun".^{[citation needed]}

Development of the company

Horiba was founded in 1945 by Masao Horiba, who graduated in nuclear physics from Kyoto University and in the early 1950s started mass-production of pH meters. The present company was registered in 1953. From 1959 until 2002, Hitachi was a principal shareholder, and the two companies retain close connections.^[6]

In 1972, the company established subsidiaries in America and Europe. In 1996–7, Horiba acquired two French companies: the specialist blood cell counter maker ABX SA (currently called Horiba ABX SAS) in 1996, and optical equipment maker Instruments SA (currently Horiba Jobin Yvon SAS) in 1997.^[7]

In 2005, Horiba acquired German company Schenck Development Test Systems (including Schenck Pegasus), expanding the automotive market product range^[8] to include engine and driveline testing tools, including brake testing and wind-tunnel balances, and the Interautomation Group of Ontario, Canada, with its real-time pre-emptive kernel Linux-based ADACS data acquisition and control software suite.^[6]

Horiba's diversification, and establishing of overseas subsidiaries, decoupled Horiba from the stagnant Japanese industrial market, and Japanese domestic sales dropped from 62% of total sales in 1995 to 35% in 2008. The Horiba group now consists of about 42 companies, spread over about 15 countries.

HORIBA Medical

The HORIBA Medical segment designs and manufactures medical instruments and reagents for the in vitro diagnostics industry. The segment, headquartered in Montpellier (France) is presents on Hematology, clinical chemistry and hemostasis markets in over 110 countries. The 1,080 employees produce 7,500 instruments and 10,000 tons of reagents annually for public and private sectors. Acquired in 1996 by HORIBA Group, the subsidiary was originally named ABX Company, founded in 1983. ABX Company was known for the launch of the smallest hematology analyzer of the world at this time, the Minos. Since joining the Japanese Group HORIBA, segment sales have continued to grow exponentially to reach 210 million of dollars (December 2014).

Products

The HORIBA Medical Segment manages the entire lifecycle of in vitro diagnostic systems worldwide that are mainly destined for biological analysis in a medical laboratory. These automated analyzers are designed for various users including patients, doctors, private laboratories, clinics and university hospitals.